A Phase II study of continuous infusion 5-fluorouracil in advanced hormone refractory prostate cancer: an Illinois cancer center study.
Lokich
J
J
D005472:Fluorouracil / Q000008:administration & dosage*; D006801:Humans; D007087:Illinois; D007263:Infusions, Parenteral; D008297:Male; D011471:Prostatic Neoplasms / Q000188:drug therapy*
D005472:Fluorouracil